Trial intelligence / Profile preview

Febuxostat vs Allopurinol in Gout

NCT01736514Phase 3Completed

Sponsor
Astellas Pharma
Start
Mar 2011
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of febuxostat in gout, sponsored by Astellas Pharma. Started Mar 2011; status: completed.

02

Drugs

febuxostat
03

Conditions

gout

Beyond the preview

Go deeper on NCT01736514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01736514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call